The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.

[1]  Christian Gluud,et al.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? , 2003, JAMA.

[2]  E. Ritz,et al.  ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy , 2003, Diabetologia.

[3]  C. Gross,et al.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.

[4]  L. Kjaergard,et al.  Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ , 2002, BMJ : British Medical Journal.

[5]  V. Fuster,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: Risk Assessment in Persons With Diabetes , 2002, Circulation.

[6]  E. Peterson,et al.  Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. , 2002, JAMA.

[7]  E. Antman,et al.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.

[8]  T. Nickelsen,et al.  [Data validity and coverage in the Danish National Health Registry. A literature review]. , 2001, Ugeskrift for laeger.

[9]  B. Gersh,et al.  Unrecognized Myocardial Infarction , 2001, Annals of Internal Medicine.

[10]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[11]  null Not Available.  World Medical Association Declaration of Helsinki , 2000 .

[12]  WMADo Helsinki.  World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. , 2000, Nursing ethics.

[13]  Douglas G Altman,et al.  Blinding in clinical trials and other studies , 2000, BMJ : British Medical Journal.

[14]  P. Kligfield,et al.  Postoperative Prophylactic Administration of &bgr;-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia , 2000, Anesthesia and analgesia.

[15]  V. Fuster,et al.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.

[16]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[17]  L. Goldman,et al.  Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). , 1999, Anesthesiology.

[18]  Farris K. Timimi,et al.  The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.

[19]  A. Gelb,et al.  Myocardial Infarction after Noncardiac Surgery , 1998, Anesthesiology.

[20]  A. Wallace,et al.  Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia , 1998, Anesthesiology.

[21]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[22]  J. Lerman.  Study design in clinical research: sample size estimation and power analysis , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[23]  R. Nesto,et al.  Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. , 1992, Journal of the American College of Cardiology.

[24]  T. Riles,et al.  Silent myocardial ischemia monitoring predicts late as well as perioperative cardiac events in patients undergoing vascular surgery. , 1992, Journal of vascular surgery.

[25]  L. Way,et al.  Long-term cardiac prognosis following noncardiac surgery , 1992 .

[26]  W. Browner,et al.  Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. , 1992, JAMA.

[27]  E. Cook,et al.  Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. , 1992, JAMA.

[28]  W. Browner,et al.  In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. , 1992, JAMA.

[29]  W. Browner,et al.  In-Hospital and Long-term Mortality in Male Veterans Following Noncardiac Surgery , 1992 .

[30]  D. Mangano,et al.  Perioperative myocardial ischemia in patients undergoing noncardiac surgery--II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. , 1991, Journal of the American College of Cardiology.

[31]  W. Browner,et al.  Association of Perioperative Myocardial Ischemia with Cardiac Morbidity and Mortality in Men Undergoing Noncardiac Surgery , 1990 .

[32]  D. Mangano.  Perioperative cardiac morbidity , 1990, Anesthesiology.

[33]  C. Coley,et al.  Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery , 1989 .

[34]  P. Coriat,et al.  Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: a randomized trial versus placebo. , 1987, Anesthesiology.

[35]  P. Coriat.  Intravenous nitroglycerin dosage to prevent intraoperative myocardial ischemia during noncardiac surgery. , 1986, Anesthesiology.

[36]  D. Kereiakes.  Myocardial infarction in the diabetic patient , 1985, Clinical cardiology.

[37]  I. R. Thomson,et al.  Failure of Intravenous Nitroglycerin to Prevent Intraoperative Myocardial Ischemia during Fentanyl–Pancuronium Anesthesia , 1984, Anesthesiology.

[38]  P. Schnohr,et al.  Electrocardiographic findings and their association with mortality in the Copenhagen City Heart Study. , 1981, European heart journal.

[39]  J. vonKnorring,et al.  Postoperative myocardial infarction: a prospective study in a risk group of surgical patients. , 1981, Surgery.

[40]  D L McGee,et al.  Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.

[41]  L Goldman,et al.  Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.

[42]  S. Dack.  POSTOPERATIVE MYOCARDIAL INFARCTION. , 1963, The American journal of cardiology.

[43]  C. Dahlöf,et al.  Controlled-release metoprolol compared with atenolol in asthmatic patients: Interaction with terbutaline , 2004, European Journal of Clinical Pharmacology.

[44]  J. Cruickshank.  Beta-Blockers and Diabetes: The Bad Guys Come Good , 2002, Cardiovascular Drugs and Therapy.

[45]  S. Kimmel,et al.  Perioperative β-blocker withdrawal and mortality in vascular surgical patients , 2001 .